Cafepharma Today

Memorial Day Weekend 2025
We wish all our US visitors a safe and enjoyable holiday weekend. We remember those who have given their lives to defend and protect our country.

CP Today will resume on Tuesday, May 27

*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

What's Next for This Biotech?
Motley Fool
Wednesday, November 6, 2013 - 3:32pm
tags:
Exelixis
Rockwell Medical: Significant Growth Potential With New State-Of-The-Art Dialysis Drug
Seeking Alpha
Wednesday, November 6, 2013 - 11:23am
tags:
Rockwell Medical, dialysis, Soluble Ferric Pyrophosphate
Jazz Pharma Q3 Solid, But Competitive Worries Loom
Investors.com
Wednesday, November 6, 2013 - 11:21am
tags:
earnings, Jazz Pharmaceuticals
InterMune says it is selling 6.5M shares to fund marketing and studies of lung disease drug
Yahoo/AP
Wednesday, November 6, 2013 - 11:21am
tags:
InterMune, stock offering, Esbriet
Isis Pharma Posts Lower Q3 Loss
Yahoo/Zacks
Wednesday, November 6, 2013 - 11:20am
tags:
earnings, Isis Pharmaceuticals
Analyst ranks the top 11 pharma giants' prospects, putting GSK on top
Fierce Biotech
Wednesday, November 6, 2013 - 10:39am
tags:
GSK, Bayer, Sanofi, Novartis, JNJ, Bristol-Myers Squibb, Merck, AbbVie, Eli Lilly, Pfizer, AstraZeneca
FDA puts a clamp on Curis cancer drug program after patient dies of liver failure
Fierce Biotech
Wednesday, November 6, 2013 - 10:37am
tags:
liver failure, Genentech, FDA, Curis, CUDC-427, breast cancer
Johnson & Johnson: Assessing Reputational Damage
Seeking Alpha
Wednesday, November 6, 2013 - 10:30am
tags:
JNJ
Bristol-Myers Squibb First to Japan in New Hepatitis C Therapy Race
Motley Fool
Wednesday, November 6, 2013 - 10:27am
tags:
Japan, Bristol-Myers Squibb, hepatitis C, asunaprevir
Can This Biotech Company Build a New Pillar of Growth?
Motley Fool
Wednesday, November 6, 2013 - 10:16am
tags:
Celgene
Merck Seen Unlocking $13 Billion With Breakup: Real M&A
Bloomberg
Wednesday, November 6, 2013 - 9:35am
tags:
Merck, M&A, restructuring, consumer products, animal health
CardioDx aims for $92M IPO
Mass Device
Wednesday, November 6, 2013 - 9:16am
tags:
CardioDx, IPOs, devices
Auxilium profit beats estimates as acquisition boosts sales
Yahoo/Reuters
Wednesday, November 6, 2013 - 8:42am
tags:
Auxilium, earnings
Testosterone Drugs Raise Heart Risk in $1 Billion Market
Bloomberg
Wednesday, November 6, 2013 - 8:34am
tags:
testosterone, Eli Lilly, Actavis, Androgel, Axiron, AbbVie, Androderm
What Cytori Therapeutics Isn't Telling Investors About Its Asian Partner
TheStreet.com
Wednesday, November 6, 2013 - 8:29am
tags:
Cytori
Sexual harassment suit against AstraZeneca removed to federal court
West Virginia Record
Wednesday, November 6, 2013 - 8:28am
tags:
sexual harassment, AstraZeneca
Novartis plots sales cuts in U.K. amid R&D restructuring
Fierce Pharma
Wednesday, November 6, 2013 - 8:27am
tags:
UK, R&D, Novartis, layoffs
3 Biotechs Falling Like a Knife
Motley Fool
Wednesday, November 6, 2013 - 8:26am
tags:
Immunomedics, Inovio, Ariad Pharmaceuticals
Roche Pacing the Field in the Biotech Race
TheStreet.com
Wednesday, November 6, 2013 - 8:20am
tags:
Roche, Amgen, Gilead, Sanofi, Celgene
Karyopharm Therapeutics IPO Looks Promising
Seeking Alpha
Wednesday, November 6, 2013 - 8:19am
tags:
Karyopharm, IPOs, Pfizer, Aveo Oncology, ONYX Pharmaceuticals

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.